Abstract Objective To study expression of adenoviral-mediated Hath1-EGFP gene in the guinea pig co• chlea after transfer through intact round window membrane(RWM), and to assess its effects on hearing. Methods Twenty adult guinea pigs were used, of which: 12 were surgically inoculated with Ad-Ha• th1-EGFP in the bony groove of round window niche, and 8 with artificial perilymph. Auditory brainstem response(ABR) thresholds were determined in all animals before and 5 days after surgery. On post-sur• gery day 5 and day 14, animals were sacrificed and whole mounts of cochlea and frozen sections were ex• amined. Results ABR tests showed no significant change of hearing after the surgery. Strong fluorescence staining in the cochleae was seen in Ad-Hath1-EGFP groups. The highest levels of gene expression were seen in the post-surgery day 5 group with little decrease on post-surgery day 14.The contralateral co• chlea and those in the control groups were free of fluorescence staining. Conclusion The transgenic Ha• th1-EGFP can be effectively delivered into the inner ear through intact RWM, in an atraumatic manner.
Introduction
As neurosensory cells in the mammalian auditory system--cochlear hair cells can transduce sound stimulation into electrical signals which are con• veyed to CNS through acoustic nerve to maintain normal hearing. However, many factors including excessive sound stimulation, ageing， ototoxic drugs and autoimmune diseases can induce irre• versible damages of cochlear hair cells, resulting in permanent sensorineural hearing loss. Previous studies have demonstrated that although spontane• ous replacement responses can be found in birds and lower vertebrates after hair cells idamage， re• generation of hair cells and recovery of hearing function are yet to be found in the mature mamma• lian cochlea 1 . In recent years research reportes concerning application of exogenous genes with in• duction and differentiation-promoting functions in the regeneration of adult mammalian inner ear hair cells have challenged the conventional idea that adult mammalian inner ear hair cells cannot regenerate 2 . The delicate cochleas structure， poses a difficult challenge effective yet safe transfer of target genes into the cochlea without cochlear structure damage. The aim of this in vivo study is to investigate the possibility of gene delivery through the intact round window membrane using an adenoviral vector system without cochlea struc• ture damage in a guinea pig model. The results from this study show significant levels of Ha• th1-EGFP gene expression in the cochlea, and may serve as a foundation for further study on in• ner ear gene therapy. were provided by Prof.Gao (Genentech USA )
1.２ Animals Randomly bred Hartley-strain guin• ea pigs weighing 250-300 g were used in this study. Twenty guinea pigs were randomly divided into a control（n = 8） , and an experiment group （n=12). The left ear served as the test ear .
Auditory brainstem response（ABR）
Under gen• eral anesthesia, a needle electrode was placed at the vertex as the recording electrode, and another two needle electrodes into both ears as the refer• ence. The ground electrode was placed subcutane• ously at the nose. Stimuli were Clicks（0.1 ms） , 1024 responses were superimposed bandpass-fil• tered （80~3 000 Hz） , and then averaged on an Intel• ligent Hearing System Smart EP2.22 system（IHS USA） which was also used for analyzing the re• cordings. ABR thresholds were determined via vi• sual identification of reproducible responses with descending click intensities at 10 dB steps. ABR threshold were tested before and five days after operative procedure for each animal.
1. ４ Surgical procedures Under general anesthe• sia, the tympanic bulla was opened, and the round window niche exposed. A approximately 5ul Ad-Hath1-EGFP（experiment group）or artificial perilymph（control group） was injected into the round window niche . To prevent immediate back• flow of the viral suspension, the cannula was left in place for 5 min following the inoculation. The tympanic bulla then was closed with a muscle flap and the incision closed with sutures.
1.5
Cochlear whole mount preparation Animals were sacrificed 5 days or 14 days after surgery（3 ani• mals from the experiment group, and 2 animals from the control group） . Following decapitation under deep anesthesia, the temporal bones were quickly opened and the stapes removed. The round window membrane and cochlear tips were perforated using a fine needle. The cochlea was gently perfused with 4% paraformaldehyde fixative in 10mM phosphate buffered saline（PBS） , pH 7.4, through the cochlea tip. The entire temporal bones was immersed in the fixative for 2 hours and rinsed in 10 mM PBS twice. The whole mount was then examined under a fluorescence microscope.
1. ６ Frozen section preparation Three animals from the experiment group and 2 from the control group were sacrificed 5 days or 14 days after sur• gery by decapitation under deep anesthesia. Both temporal bones were removed and the fluid spac• es of the inner ear perfused with 4% paraformalde• hyde in phosphate buffer saline（PBS） . The speci• mens were decalcified for 3 days in 10% EDTA, cryo-protected in 30% sucrose for 24h and trans• ferred into cryo-molds filled with OCT embedding compound. The molds were vacuumed at low pres• sure for 10 min, to remove trapped air. The speci• men was kept in OCT at 4℃ for 24 h to for ade• quate infiltration into the inner ear. It was appro• priately aligned and, snap-frozen in liquid nitro• gen for 0.5 min before sectioning. Sections（8 μm thick）were cut on a Leica Cryomicrotom 2800. A pproximately 200 serial sections were collected from each ear onto electrostatic glass slides, which were examined under a fluorescence micro• scope.
1.７ Immunocytochemistry and Histological Analysis
The cochlea whole mount was stained with Pro• pedium Iodide（PI Sigma） , a DNA specific labling agent, and then examined using a Radiance2100 con-focal fluorescence microscope （Bio-Rad com 
３ Discussion
Cochlear gene transfer studies in animal models have utilized mainly two methods: direct injection through the round window membrane（RWM） or intracochlear infusion through a cochleostomy. However, structural damage from surgical trauma and inflammatory reaction and hearing loss associ• ated with these methods lead us to search for a less invasive delivery method. Another concern is injury to adjacent important structures caused by surgical maneuvers, which has restricted its appli• cation 5, 6 . An alternative technique in gene transfer is through the cerebrospinal fluid and the induc• tion is achieved via the cochlear aqueduct to reach both inner ears. However, animal studies show that expression of target genes in the cochlea, lim• ited by the number of receptors, is mainly distribut• ed in basal turns bilaterally. Expression is also seen in the bottom part of the brain, raising the question of a potential risk to the brain . These have restricted clinical application of such tech• niques ervation of normal physiological functions of the cochlea. Examinatgion of the middle ear cavity at 5 and 14 days post-surgery in this study showed no signs of inflammatory reaction or hemorrhage in either the middle ear or inner ear. There was no significant difference in ABR threshold before and after the surgery or between the experiment and control groups(P > 0.05), suggesting no influence on hearing by the surgical maneuvers. Punctiform loss of outer hair cells seen only in inoculated ears may be indicative of injury to adjacent hair cells from viral biotoxicity, which seems to have little ef• fects on auditory function.
The carrier employed in this study, i.e. AD virus, has a high transfection efficiency（possibly 100%） , capable of infecting both dividing and nondividing cells. It is easy to culture and purify and can be prepared at high titres. Its unconformity with host cell genome makes it a relative safe carrier, with a bright future of application 11, 12 . Our data show that the target gene was widely expressed in the co• chlea at 5 days after the surgery, involving the sup• porting cells and spiral ganglion cells. There was a gradual decrease in the intensity of fluorescent light from the basilar turn to the top turn, suggest• ing that the target gene carried by AD virus was disperse throughout the whole cochlear area via in• ner ear lymph fluid, with relatively high expres• sion in the region adjacent to injection compared to other areas. The difference in target gene ex• pression in the cochlea may be due to relatively slow circulation metabolism of inner ear lymph flu• id or the inability of the defective AD virus to cross the labyrinth membrane between the inner and outer spatium perilymphaticum. In addition, the tropism of the virus towards the tissue cell is determined by the virus receptors in the tissues. Vi• rus adhesion towards tissue cells usually takes sev• eral to dozens of minutes, which is influenced not only by the virus adhesion protein, the electrifica• tion condition and cellular structure of the specif• ic cell receptor, but also by various environmental factors including humidity, presence of ions, pH value and route of viral invasion 13 . The minimal change in fluorescent light intensity between day 5 and day 14 day indicates gene ex• pression stability. However, abundant early and late protein production following virus injection of virus can cause host immune reaction and subse• quent clearance, which can limit expression peri• od. By combining recombinated AD virus and im• mune depressant, some researchers have been able to prolong the expression period 14 . Further in• vestigation is needed to achieve long-term expres• sion of exogenous gene carried by AD virus.
Safe drug administration via appropriate route is especially important in treating inner ear dis• eases 15 . The technique used in the present study is easy, atraumatic, and effective in delivering trans• genes through intact RWM. Compared with other more invasive gene delivery methods, this tech• nique represents a safer and more clinically viable route of cochlear gene delivery. The technique at its present form needs further improvements. Audi• tory thresholds need to be systematically tested at more time points and at different frequencies. Spa• tial and temporal characteristics of gene expres• sion in the inner ear with hearing damage induced by drug or noise need to be studied and gene trans• duction efficiency need to be quantified.
